Publications by authors named "Ruby F Meredith"

Claim this Profile
B
Biological Effective Radiation Dose for Multiple Myeloma Palliation.
Ruby F Meredith, John R Bassler, Andrew M McDonald, John M Stahl, David T Redden

Adv Radiat Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
Ayman Saad, Alankrita Taneja, Antonio Di Stasi, Rehan Sarmad, Rivvi Kukkamalla, Ruby F Meredith

Bone Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.
Ruby F Meredith, Julien J Torgue, Tania A Rozgaja, Eileen P Banaga, Patty W Bunch

Am J Clin Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases.
John B Fiveash, Waleed O Arafat, George E Naoum, Barton L Guthrie, Stephen M Sawrie, Ruby F Meredith

Adv Radiat Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
Michael Ljungberg, Anna Celler, Mark W Konijnenberg, Keith F Eckerman, Yuni K Dewaraja, Ruby F Meredith

J Nucl Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib combined with radiation: in vivo model of interaction.
Ruby F Meredith, Kevin P Raisch, James A Bonner, Donald J Buchsbaum, Willliam E Grizzle

Cancer Biother Radiopharm· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.
Ruby F Meredith, Julien Torgue, Michael T Azure, Sui Shen, Souheil Saddekni

Cancer Biother Radiopharm· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications.
Yuni K Dewaraja, Michael Ljungberg, Alan J Green, Pat B Zanzonico, Eric C Frey, Ruby F Meredith

J Nucl Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma.
Christos Vaklavas, Ruby F Meredith, Sui Shen, Susan J Knox, Ivana N Micallef

Cancer Biother Radiopharm· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
Sui Shen, Andres Forero, Ruby F Meredith, Albert F LoBuglio

Cancer Biother Radiopharm· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal dosimetry.
Barry W Wessels, Roger G Dale, Marta Cremonesi, Ruby F Meredith, Alan J Green

Cancer Biother Radiopharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.
Andres Forero-Torres, Mansoor N Saleh, Janice A Galleshaw, Cheryl F Jones, Jatin J Shah, Ruby F Meredith

Clin Breast Cancer· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Jimmy J Caudell, Philip E Schaner, Renee A Desmond, Ruby F Meredith, Sharon A Spencer

Int J Radiat Oncol Biol Phys· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
George Sgouros, John C Roeske, Michael R McDevitt, Stig Palm, Barry J Allen, Ruby F Meredith

J Nucl Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer.
Jimmy J Caudell, Ruby F Meredith, Sharon A Spencer, Kimberley S Keene, M Christian Dobelbower

Int J Radiat Oncol Biol Phys· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.
Sui Shen, Andres Forero, Ruby F Meredith, Jatin J Shah, Susan J Knox

J Nucl Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
Barbara A Murphy, Jennifer L Beaumont, John Isitt, Adam S Garden, Clement K Gwede, Ruby F Meredith

J Pain Symptom Manage· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.
Darrell R Fisher, Sui Shen, Ruby F Meredith

J Nucl Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Jimmy J Caudell, Philip E Schaner, Ruby F Meredith, Julie L Locher, Lisle M Nabell

Int J Radiat Oncol Biol Phys· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Barry W Wessels, Mark W Konijnenberg, Roger G Dale, Hazel B Breitz, Marta Cremonesi, Ruby F Meredith

J Nucl Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment.
Jimmy J Caudell, Stephen M Sawrie, Sharon A Spencer, Renee A Desmond, William R Carroll, Ruby F Meredith

Int J Radiat Oncol Biol Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radionuclide therapy.
Lawrence E Williams, Gerald L DeNardo, Ruby F Meredith

Med Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
David M Brizel, Barbara A Murphy, David I Rosenthal, Kishan J Pandya, Stefan Glück, Ruby F Meredith

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae.
Ruby F Meredith, Sui Shen, Andres Forero, Albert LoBuglio

J Nucl Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
Ruby F Meredith, Donald J Buchsbaum, Ronald D Alvarez, Albert F LoBuglio

Clin Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis